# Warner Music Group Corp.: financial statements, quarterly

WMG · Nasdaq · CIK 1319161 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Sep 30

Pages: [Overview](/companies/wmg.md) · [Financials](/companies/wmg/financials.md) · [Filings](/companies/wmg/filings.md) · [Insiders](/companies/wmg/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/wmg/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-09-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | Q4 FY2024 (2024-09-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q4 FY2025 (2025-09-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,586 d](/filings/0001319161-25-000034.md) | [1,748](/filings/0001319161-25-000007.md) | [1,494](/filings/0001319161-25-000016.md) | [1,554](/filings/0001319161-25-000023.md) | [1,630 d](/filings/0001319161-25-000034.md) | [1,666](/filings/0001319161-26-000010.md) | [1,484](/filings/0001319161-26-000022.md) | [1,689](/filings/0001319161-26-000032.md) | [1,868 d](/filings/0001319161-25-000034.md) | [1,840](/filings/0001319161-26-000010.md) | [1,732](/filings/0001319161-26-000022.md) | [1,864](/filings/0001319161-26-000032.md) |
| Cost of revenue | $m | [845 d](/filings/0001319161-25-000034.md) | [880](/filings/0001319161-25-000007.md) | [791](/filings/0001319161-25-000016.md) | [830](/filings/0001319161-25-000023.md) | [854 d](/filings/0001319161-25-000034.md) | [894](/filings/0001319161-26-000010.md) | [791](/filings/0001319161-26-000022.md) | [913](/filings/0001319161-26-000032.md) | [1,034 d](/filings/0001319161-25-000034.md) | [987](/filings/0001319161-26-000010.md) | [930](/filings/0001319161-26-000022.md) | [1,010](/filings/0001319161-26-000032.md) |
| Selling, general and administrative | $m | [473 d](/filings/0001319161-25-000034.md) | [476](/filings/0001319161-25-000007.md) | [446](/filings/0001319161-25-000016.md) | [462](/filings/0001319161-25-000023.md) | [495 d](/filings/0001319161-25-000034.md) | [474](/filings/0001319161-26-000010.md) | [450](/filings/0001319161-26-000022.md) | [471](/filings/0001319161-26-000032.md) | [494 d](/filings/0001319161-25-000034.md) | [458](/filings/0001319161-26-000010.md) | [460](/filings/0001319161-26-000022.md) | [464](/filings/0001319161-26-000032.md) |
| Operating income | $m | [212 d](/filings/0001319161-25-000034.md) | [354](/filings/0001319161-25-000007.md) | [119](/filings/0001319161-25-000016.md) | [207](/filings/0001319161-25-000023.md) | [143 d](/filings/0001319161-25-000034.md) | [214](/filings/0001319161-26-000010.md) | [168](/filings/0001319161-26-000022.md) | [169](/filings/0001319161-26-000032.md) | [143 d](/filings/0001319161-25-000034.md) | [288](/filings/0001319161-26-000010.md) | [264](/filings/0001319161-26-000022.md) | [305](/filings/0001319161-26-000032.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [58.0 d](/filings/0001319161-25-000034.md) | [72.0](/filings/0001319161-25-000007.md) | [18.0](/filings/0001319161-25-000016.md) | [30.0](/filings/0001319161-25-000023.md) | [3.0 d](/filings/0001319161-25-000034.md) | [89.0](/filings/0001319161-26-000010.md) | [29.0](/filings/0001319161-26-000022.md) | [5.0](/filings/0001319161-26-000032.md) | [(3.0) d](/filings/0001319161-25-000034.md) | [71.0](/filings/0001319161-26-000010.md) | [73.0](/filings/0001319161-26-000022.md) | [67.0](/filings/0001319161-26-000032.md) |
| Net income | $m | [152 d](/filings/0001319161-25-000034.md) | [159](/filings/0001319161-25-000007.md) | [96.0](/filings/0001319161-25-000016.md) | [139](/filings/0001319161-25-000023.md) | [41.0 d](/filings/0001319161-25-000034.md) | [236](/filings/0001319161-26-000010.md) | [36.0](/filings/0001319161-26-000022.md) | [(16.0)](/filings/0001319161-26-000032.md) | [109 d](/filings/0001319161-25-000034.md) | [176](/filings/0001319161-26-000010.md) | [183](/filings/0001319161-26-000022.md) | [204](/filings/0001319161-26-000032.md) |
| Diluted EPS | $ per share | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Basic EPS | $ per share | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue, us-gaap:CostOfGoodsAndServicesSold
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: not reported
- Basic EPS: not reported

## Balance sheet

| Line item | Unit | FY2023 (2023-09-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | FY2024 (2024-09-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | FY2025 (2025-09-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.6](/filings/0001319161-24-000039.md) | [0.8](/filings/0001319161-24-000010.md) | [0.6](/filings/0001319161-24-000020.md) | [0.6](/filings/0001319161-24-000027.md) | [0.7](/filings/0001319161-25-000034.md) | [0.8](/filings/0001319161-25-000007.md) | [0.6](/filings/0001319161-25-000016.md) | [0.5](/filings/0001319161-25-000023.md) | [0.5](/filings/0001319161-26-000032.md) | [0.8](/filings/0001319161-26-000010.md) | [0.7](/filings/0001319161-26-000022.md) | [0.6](/filings/0001319161-26-000032.md) |
| Current assets | $bn | [2.4](/filings/0001319161-24-000039.md) | [2.6](/filings/0001319161-24-000010.md) | [2.5](/filings/0001319161-24-000020.md) | [2.5](/filings/0001319161-24-000027.md) | [2.6](/filings/0001319161-25-000034.md) | [2.7](/filings/0001319161-25-000007.md) | [2.6](/filings/0001319161-25-000016.md) | [2.7](/filings/0001319161-25-000023.md) | [2.8](/filings/0001319161-26-000032.md) | [3.0](/filings/0001319161-26-000010.md) | [3.2](/filings/0001319161-26-000022.md) | [3.3](/filings/0001319161-26-000032.md) |
| Total assets | $bn | [8.5](/filings/0001319161-24-000039.md) | [9.0](/filings/0001319161-24-000010.md) | [8.7](/filings/0001319161-24-000020.md) | [8.8](/filings/0001319161-24-000027.md) | [9.2](/filings/0001319161-25-000034.md) | [9.1](/filings/0001319161-25-000007.md) | [9.6](/filings/0001319161-25-000016.md) | [9.8](/filings/0001319161-25-000023.md) | [9.8](/filings/0001319161-26-000032.md) | [10.0](/filings/0001319161-26-000010.md) | [10.6](/filings/0001319161-26-000022.md) | [10.7](/filings/0001319161-26-000032.md) |
| Current liabilities | $bn | [3.5](/filings/0001319161-24-000039.md) | [3.7](/filings/0001319161-24-000010.md) | [3.5](/filings/0001319161-24-000020.md) | [3.6](/filings/0001319161-24-000027.md) | [3.9](/filings/0001319161-25-000034.md) | [3.9](/filings/0001319161-25-000007.md) | [3.9](/filings/0001319161-25-000016.md) | [4.1](/filings/0001319161-25-000023.md) | [4.2](/filings/0001319161-26-000032.md) | [4.3](/filings/0001319161-26-000010.md) | [4.4](/filings/0001319161-26-000022.md) | [4.4](/filings/0001319161-26-000032.md) |
| Total liabilities | $bn | [8.1](/filings/0001319161-24-000039.md) | [8.4](/filings/0001319161-24-000010.md) | [8.1](/filings/0001319161-24-000020.md) | [8.2](/filings/0001319161-24-000027.md) | [8.5](/filings/0001319161-25-000034.md) | [8.4](/filings/0001319161-25-000007.md) | [8.8](/filings/0001319161-25-000016.md) | [9.0](/filings/0001319161-25-000023.md) | [9.1](/filings/0001319161-26-000032.md) | [9.2](/filings/0001319161-26-000010.md) | [9.6](/filings/0001319161-26-000022.md) | [9.6](/filings/0001319161-26-000032.md) |
| Long-term debt | $bn | [4.0](/filings/0001319161-24-000039.md) | [4.0](/filings/0001319161-24-000010.md) | [4.0](/filings/0001319161-24-000020.md) | [4.0](/filings/0001319161-24-000027.md) | [4.0](/filings/0001319161-25-000034.md) | [4.0](/filings/0001319161-25-000007.md) | [4.0](/filings/0001319161-25-000016.md) | [4.1](/filings/0001319161-25-000023.md) | [4.1](/filings/0001319161-25-000034.md) | [4.4](/filings/0001319161-26-000010.md) | [4.7](/filings/0001319161-26-000022.md) | [4.7](/filings/0001319161-26-000032.md) |
| Current portion of debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $bn | [0.3](/filings/0001319161-24-000039.md) | [0.5](/filings/0001319161-24-000010.md) | [0.4](/filings/0001319161-24-000020.md) | [0.5](/filings/0001319161-24-000027.md) | [0.5](/filings/0001319161-25-000034.md) | [0.5](/filings/0001319161-25-000007.md) | [0.6](/filings/0001319161-25-000016.md) | [0.6](/filings/0001319161-25-000023.md) | [0.6](/filings/0001319161-26-000032.md) | [0.7](/filings/0001319161-26-000010.md) | [0.7](/filings/0001319161-26-000022.md) | [0.9](/filings/0001319161-26-000032.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent, us-gaap:LongTermDebt
- Current portion of debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-09-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | Q4 FY2024 (2024-09-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q4 FY2025 (2025-09-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [338 d](/filings/0001319161-25-000034.md) | [293](/filings/0001319161-25-000007.md) | [(31.0) d](/filings/0001319161-25-000016.md) | [188 d](/filings/0001319161-25-000023.md) | [304 d](/filings/0001319161-25-000034.md) | [332](/filings/0001319161-26-000010.md) | [69.0 d](/filings/0001319161-26-000022.md) | [46.0 d](/filings/0001319161-26-000032.md) | [231 d](/filings/0001319161-25-000034.md) | [440](/filings/0001319161-26-000010.md) | [126 d](/filings/0001319161-26-000022.md) | [142 d](/filings/0001319161-26-000032.md) |
| Capital expenditure | $m | [38.0 d](/filings/0001319161-25-000034.md) | [29.0](/filings/0001319161-25-000007.md) | [26.0 d](/filings/0001319161-25-000016.md) | [28.0 d](/filings/0001319161-25-000023.md) | [33.0 d](/filings/0001319161-25-000034.md) | [36.0](/filings/0001319161-26-000010.md) | [36.0 d](/filings/0001319161-26-000022.md) | [39.0 d](/filings/0001319161-26-000032.md) | [28.0 d](/filings/0001319161-25-000034.md) | [20.0](/filings/0001319161-26-000010.md) | [27.0 d](/filings/0001319161-26-000022.md) | [28.0 d](/filings/0001319161-26-000032.md) |
| Dividends paid | $m | [89.0 d](/filings/0001319161-25-000034.md) | [89.0](/filings/0001319161-25-000007.md) | [89.0](/filings/0001319161-24-000020.md) | [89.0](/filings/0001319161-24-000027.md) | [94.0 d](/filings/0001319161-25-000034.md) | [94.0](/filings/0001319161-26-000010.md) | [95.0](/filings/0001319161-25-000016.md) | [94.0](/filings/0001319161-25-000023.md) | [100 d](/filings/0001319161-25-000034.md) | [100](/filings/0001319161-26-000010.md) | [100](/filings/0001319161-26-000022.md) | [100](/filings/0001319161-26-000032.md) |
| Share repurchases | $m | not reported | [0.0](/filings/0001319161-25-000007.md) | [0.0 d](/filings/0001319161-25-000016.md) | [0.0 d](/filings/0001319161-25-000023.md) | [0.0 d](/filings/0001319161-25-000034.md) | [2.0](/filings/0001319161-26-000010.md) | [0.0 d](/filings/0001319161-26-000022.md) | [1.0 d](/filings/0001319161-26-000032.md) | [13.0 d](/filings/0001319161-25-000034.md) | [26.0](/filings/0001319161-26-000010.md) | [22.0 d](/filings/0001319161-26-000022.md) | [0.0 d](/filings/0001319161-26-000032.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | period not labelled (2010-06-30) | Q3 FY2012 (2011-06-30) |
| --- | --- | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [150](/filings/0001193125-11-209307.md) | [152](/filings/0001193125-11-209307.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 1,069 at 2020-01-31, from the cover of the [10-Q filed 2020-01-31](/filings/0001319161-20-000008.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:36 ET. No prices; not investment advice.